Towards a glioma model for surgical technique evaluation in the rat

References

• Kleihues P, Burger PC, Aldape KD, et al. Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th ed. Lyon: IARC Press, 2007:p. 33.
   Google Scholar
• Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62:753–66.
   PubMed Web of Science ®Google Scholar
• Laws ER Jr, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project. J Neurosurg 2003;99: 467–73.
   PubMed Web of Science ®Google Scholar
• Tonn JC, Stummer W. Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks and pitfalls. Clin Neurosurg 2008;55:20–26.
   PubMedGoogle Scholar
• LeRoux PD, Berger MS, Ojemann GA, Wang K, Mack LA. Correlation of intraoperative ultrasound tumor volumes and margins with preoperative computerized tomography scans. An intraoperative method to enhance tumor resection. J Neurosurg 1989;71:691–8.
   Google Scholar
• Stadlbauer A, Moser E, Gruber S, et al. Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. J Neurosurg 2004;101:287–94.
   PubMed Web of Science ®Google Scholar
• Oertel J, von Butlar E, Schroeder HWS, Gaab MR. Prognosis of gliomas in the 70ies and today. Neurosurg Focus 2005;18:E12.
   Google Scholar
• Vauleon E, Avril T, Collet B, Mosser J, Quillien V. Overview of cellular immunotherapy for patients with glioblastoma. Clin Dev Immunol 2010;Article ID 689171, 18 pages. doi:10.1155/2010/689171.
   Google Scholar
• Hickey MJ, Malone CC, Erickson KL, et al. Cellular and vaccine therapeutic approaches for gliomas. J Transl Med 2010;8:100.
   PubMed Web of Science ®Google Scholar
• Wick W, Platten M, Weller M. New (altenative) temozolomide regimens for the treatment of glioma. Neuro Oncol 2008;11: 69–79.
   PubMed Web of Science ®Google Scholar
• Perry JR, Mason WP, Fulton D, et al. Phase II Trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. J Clin Oncol 2010;28:2051–7.
   PubMed Web of Science ®Google Scholar
• Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J Neurooncol 2009;94:299–312.
   PubMed Web of Science ®Google Scholar
• Grobben B, De Deyn PP, Slegers H. Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 2002;310:257–70.
   PubMed Web of Science ®Google Scholar
• Orringer DA, Chen T, Huang DL, et al. The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents. Neurosurgery 2010; 66:736–43
   PubMed Web of Science ®Google Scholar
• Ozawa T, Britz GW, Kinder DH, et al. Bromophenol blue staining of tumors in a rat glioma model. Neurosurgery 2005;57:1041–7.
   PubMed Web of Science ®Google Scholar
• Jia W, Jackson-Cook C, Graf MR. Tumor-infiltrating, meloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vacination model. J Neuroimmunol 2010;223:20–30.
   PubMed Web of Science ®Google Scholar
• Akbar U, Jones T, Winestone J, et al. Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection. J Neurooncol 2009;94:203–12.
   PubMed Web of Science ®Google Scholar
• Zhang X, Jiang F, Kalkanis SN, et al. Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat. Photochem Photobiol 2006;82:1704–11.
   PubMed Web of Science ®Google Scholar
• Emerich DF, Winn SR, Hu Y, et al. Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors. Pharm Res 2000;17:767–75.
   PubMed Web of Science ®Google Scholar
• Bampoe J, Glen J, Mackenzie I, Porter P, Bernstein M. Effect of implant dose/volume and surgical resection on survival in a rat glioma brachytherapy model: implications for brain tumor therapy. Neurosurgery 1997;41:1374–83.
   PubMed Web of Science ®Google Scholar
• Oertel J, Wagner W, Piek J, Schroeder H, Gaab M. Waterjet dissection of gliomas – experience with 51 procedures. Minim Invas Neurosurg 2004;47:154–9.
   PubMedGoogle Scholar
• Keiner D, Gaab MR, Backhaus, V, Piek J, Oertel J. Water jet dissection in neurosurgery: an update after 208 procedures with special reference to surgical technique and complications. Neurosurgery 2010;67:342–54.
   PubMed Web of Science ®Google Scholar
• Piek J, Oertel J, Gaab MR. Waterjet dissection in neurosurgical procedures: clinical results in 35 patients. J Neurosurg 2002;96: 690–96.
   PubMed Web of Science ®Google Scholar
• Oertel J, Gaab MR, Warzok R, Piek J. Waterjet dissection in the brain: review of the experimental and clinical data with special reference to meningioma surgery. Neurosurg Rev 2003;26: 168–74.
   PubMed Web of Science ®Google Scholar
• Oertel J, Gaab MR, Piek J. Waterjet resection of brain metastases – first clinical results with 10 patients. EJSO 2003;29:407–14.
   PubMed Web of Science ®Google Scholar
• Oertel J, Gaab MR, Runge U, Schroeder HWS, Piek J. Waterjet dissection versus ultrasonic aspiration in epilepsy surgery. Neurosurg 2005;56:142–146.
   PubMedGoogle Scholar
• Foersch S, Heimann A, Ayyad A, et al. Confocal laser endomicroscopy for diagnosis and histomorphologic imaging of brain tumors in vivo. PloS One 2012;7:e41760. doi:10.1371/journal.pone.0041760
   Web of Science ®Google Scholar
• Fross RD, Warnke PC, Groothius DR. Blood flow and blood- to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research. J Neurooncol 1991;11: 185–97.
   PubMed Web of Science ®Google Scholar
• Morantz RA, Wood GW, Foster M, Clark M, Gollahon K. Macrophages in experimental and human brain tumors. Part 1: studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. J Neurosurg 1979;50:298–304.
   PubMed Web of Science ®Google Scholar
• Emerich DF, Winn SR, Hu Y, et al. Injectable Chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors. Pharm Res 2000;17:767–75.
   PubMed Web of Science ®Google Scholar
• Benda P, Lightbody J, Sato G, Lewine L, Sweet W. Differentiated rat glial cell strain in tissue culture. Science 1968;161:370–1.
   PubMed Web of Science ®Google Scholar
• Sibenaller ZA, Etame AM, Ali MM, et al. Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg Focus 2005;19:E1.
   Google Scholar
• Goetz CM, Rachinger W, Decker M, et al. Distribution of labelled anti-tenascin antibodies and fragments after injection into intact or partly resected C6-gliomas in rats. Cancer Immunol Immunother 2005;54:337–44.
   PubMed Web of Science ®Google Scholar
• Zhang F, Xie J, Liu G, et al. In vivo MRI tracking of cell invasion and migration in a rat glioma model. Mol Imaging Biol 2011;13: 695–701.
   PubMed Web of Science ®Google Scholar